Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

IMpassion131 investigators

Research output: Contribution to journal › Article › peer-review

360 Scopus citations

Fingerprint

Dive into the research topics of 'Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences